HHGA
DGX icon

Halbert Hargrove Global Advisors’s Quest Diagnostics DGX Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365 Buy
+2
New +$393 ﹤0.01% 577
2025
Q2 		– Sell
-1
Closed -$170 – 399
2025
Q1 		$170 Buy
+1
New +$164 ﹤0.01% 602

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Halbert Hargrove Global Advisors's DGX Position: Q2 2026 in Review

Halbert Hargrove Global Advisors opened a new position in Quest Diagnostics (DGX) in Q2 2026: 2 shares worth $365. The stake represents ﹤0.01% of the portfolio and ranks #577 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in DGX as recently as Q1 2025.

Halbert Hargrove Global Advisors first reported a position in DGX in Q1 2025 and has held it in 2 quarters since. 277 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Halbert Hargrove Global Advisors held 2 shares of Quest Diagnostics worth $365 as of Q2 2026.
  • Quest Diagnostics was a new Halbert Hargrove Global Advisors position in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #577 holding.
  • Halbert Hargrove Global Advisors first reported a position in Quest Diagnostics in Q1 2025 and has held it in 2 quarters since.
  • 277 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.